Lonza and Sanquin Partner for Commercialization of Specialized MAT Reagents for Accurate and Reliable in vitro Pyrogen Testing Read more
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases Read more
IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford Read more
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients Read more